| 1 day | +4.15% |
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 22/06/2023 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 15/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Chiara
BRD | Director/Board Member | - | 04/11/2016 |
Peter Montour
BRD | Director/Board Member | - | 30/08/2021 |
William Montour
BRD | Director/Board Member | - | 05/01/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/09/21 | Marche | Director | 350,000 | 0.1554% | ||
| 15/09/21 | Marche | 3,000,000 | 1.3322% | |||
| 15/09/21 | Marche | 22,363,312 | 9.9309% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.15% | +2,913.33% | - | - | 29.39M | ||
| +5.81% | +0.90% | +78.79% | -9.03% | 2.21B | ||
| +4.03% | +2.86% | +66.95% | +120.10% | 1.62B | ||
| +0.72% | +6.79% | -41.67% | +152.25% | 489M | ||
| +3.64% | +7.55% | +11.76% | +14.00% | 62.12M | ||
| Average | +3.66% | +4.28% | +28.96% | +69.33% | 1.1B | |
| Weighted average by Cap. | +4.53% | +2.22% | +60.03% | +57.06% |
Employees
-
Sector
Pharmaceuticals
















